/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mahesh Basyal

The University of Texas MD Anderson Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

53

Papers

214

Citations

6

h-index

6

i10-index

Mahesh Basyal is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Protein Degradation and Inhibitors & Immune Cell Function and Interaction. The author has an h-index of 6, co-authored 46 publications.

Research Topics

Acute Myeloid Leukemia Research Protein Degradation and Inhibitors Immune Cell Function and Interaction CAR-T cell therapy research Multiple Myeloma Research and Treatments

Papers by this author

works

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

2023 · Journal of Hematology & Oncology · 49 citations

https://doi.org/10.1186/s13045-023-01476-8

Nicholas J. Short Muharrem Müftüoğlu Faustine Ong Lewis Nasr

FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML

2023 · Leukemia · 18 citations

https://doi.org/10.1038/s41375-023-01897-x

Yannan Jia Weiguo Zhang Mahesh Basyal Kyung Hee Chang

Research topics

topics

Acute Myeloid Leukemia Research

Protein Degradation and Inhibitors

Immune Cell Function and Interaction

CAR-T cell therapy research

Multiple Myeloma Research and Treatments

Chat about Author

Papers

Chat

Click to start Chat